Page 77 - TD-4-2
P. 77

Tumor Discovery                                                       DRGs in HCC prognosis and immunity



            categorized into high-risk (≥mean) and low-risk (<mean)   1-, 3-, and 5-year OS in patients with HCC. Consistency
            groups based on these mean risk scores. Survival curves   indices and a calibration curve were employed to assess the
            for these subgroups were then plotted. The “survminer”   predictive accuracy of the nomogram.
            package in R software generated Kaplan-Meier curves,
            risk line plots, and scatterplots. These visualizations were   2.5. Functional enrichment analyses and
            used to compare risk score variations among patient   protein‑protein interaction
            subtypes with DRGs and to illustrate the relationship   Gene ontology (GO) and Kyoto Encyclopedia of Genes
            between risk levels and patient survival status. Receiver   and Genomes (KEGG) enrichment analyses were
            operating characteristic (ROC) curve analysis, including   employed to investigate differences in gene functions and
            survival curves at 1, 3, and 5 years, was performed using   pathways between subgroups identified by the risk model.
            the “survminer” and “timeROC” packages in R software to   Eighteen DRGs were identified between the low- and high-
            assess the prognostic power of the risk model. In addition,   risk groups in the TCGA dataset. To better understand
            risk scores and clinical factors were integrated to construct   the  biological  pathways  and  functions  of  the  identified
            univariate and multivariate Cox regression models, which   differentially expressed genes, GO enrichment analysis
            were used to evaluate the independent prognostic value of   (molecular function [MF], biological process [BP], and
            risk scores for HCC patients.                      cellular component [CC]) and KEGG pathway analysis
                                                               were conducted using the “ClusterProfiler,” “org.Hs.eg.db,”
            2.3. Analysis of the correlation between prognostic   “enrichplot,” and “ggplot2” packages of R software. A p<0.05
            and clinical features                              was considered indicative of significant enrichment.
            Risk scores and clinical data were integrated and analyzed   Protein-protein interactions (PPIs) were visualized by
            using the chi-square test to examine the correlation between   submitting differentially expressed DRGs to the STRING
            prognostic and clinical features. The chi-square test was   database (http://www.string-db.org/). The most significant
            employed to investigate the involvement of prognostic   modules (the top ten highest-rated genes) within the PPI
            characteristics in the development of HCC. Heatmaps   network were selected using the maximal clique centrality
            displaying DRGs with clinic-specific data were generated. Box   algorithm through the “CytoHubba” plugin in the
            plots based on risk scores were created to analyze the variance   Cytoscape software (version 3.8.0).
            in clinical factors and the correlation between prognostic and
            clinical characteristics. Variables such as age, sex, pathologic   2.6. GSEA
            N, pathologic M, pathological stage, and pathologic T   To investigate the potential molecular mechanisms
            were considered to determine statistical significance across   distinguishing the low-risk and high-risk groups, GSEA
            subgroups. Pathologic T, N, and M refer to tumor, node,   was performed using the “ClusterProfiler,” “enrichplot,”
            and metastasis,  respectively. In addition, further  stratified   “ggplot2,” and “org.Hs.eg.db” packages of the R software.
            analyses were performed to assess the prognostic significance   A  p<0.05 was considered indicative of significant
            of DRG characteristics within subgroups categorized by age   enrichment. Pathways with the top five highest numbers of
            (≤65 years vs. >65 years), sex (male vs. female), pathologic   molecules in the gene set were selected for mapping.
            stage (stages I – II vs. stages III – IV), tumor grade (low vs.
            high), pathologic T (stages T1 – T2 vs. stages T3 – T4), and   2.7. The relationship between prognostic signatures
            pathologic N (N0 vs. N1–2–3).                      and immune checkpoints
                                                               Given the significance of ICI immunotherapy, the
            2.4. Nomogram establishment based on risk score    association between two subgroups of HCC patients,
            and clinical variables
                                                               categorized by risk scores and 79 immune checkpoints, was
            Univariate and multivariate Cox regression analyses and   investigated, and the differences in immune checkpoint
            additional clinical variables were incorporated to assess   expression between these subgroups were assessed. Gene
            whether risk scores possess independent prognostic value   expression associated with immune checkpoints was
            in predicting outcomes. Column-line plots were generated   analyzed using the “limma” and “ggpubr” packages in the
            to evaluate the predicted likelihood of overall survival   R software, focusing on the differences between the high-
            (OS). Clinical variables and risk scores were collected,   risk and low-risk groups.
            and Cox regression modeling was applied to calculate
            hazard  ratios  (HRs)  for  each  variable.  The  relationships   2.8. Correlation analysis between genes and
            between DRG-based and clinical variables were examined.   immune infiltration
            Column-line plots were constructed using clinical factors   Immune infiltration refers to the distribution and activity
            and DRG-based risk ratings to evaluate the likelihood of   of immune cells and related molecules within tumor


            Volume 4 Issue 2 (2025)                         69                                doi: 10.36922/td.8214
   72   73   74   75   76   77   78   79   80   81   82